Author name: DrugPatentWatch

Regulatory Considerations for Biosimilar Analytical Similarity Assessments Introduction Biosimilars, or follow-on biologics, are biopharmaceuticals that are highly similar to an […]

One issue continues to loom large in healthcare: the skyrocketing costs of pharmaceuticals. This challenge has become a significant hurdle

Introduction Biosimilars, which are biologic drugs that are highly similar to an already approved biologic drug, are transforming the pharmaceutical

Introduction Have you ever found yourself scratching your head at the pharmacy counter, wondering why your “3-month supply” of medication

Risk assessment plays a crucial role in the development of generic drugs, ensuring that these products meet the required standards

Introduction China has emerged as a significant player in the global generic drug active pharmaceutical ingredient (API) market. The country’s

Introduction The pharmaceutical industry plays a crucial role in global healthcare, providing essential medications that improve and save lives. Within

A recent study published in Drug Discovery Today highlights the potential of artificial intelligence (AI) in revolutionizing drug discovery and

Pharmacokinetics (PK) plays a crucial role in the development and approval of generic drugs. PK studies help ensure that generic